Northeast Financial Consultants’s MacroGenics MGNX Stock Holding History

Northeast Financial Consultants’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$12.1K	Buy	+10,000	New	+$14.5K	﹤0.01%	299
2024 Q4	–	Sell	-10,000	Closed	-$32.9K	–	297
2024 Q3	$32.9K	Hold	10,000	–	–	﹤0.01%	289
2024 Q2	$42.5K	Hold	10,000	–	–	﹤0.01%	268
2024 Q1	$147K	Hold	10,000	–	–	0.01%	279
2023 Q4	$96.2K	Hold	10,000	–	–	0.01%	274
2023 Q3	$46.6K	Hold	10,000	–	–	﹤0.01%	281
2023 Q2	$53.5K	Hold	10,000	–	–	﹤0.01%	283
2023 Q1	$71.7K	Hold	10,000	–	–	﹤0.01%	309
2022 Q4	$67.1K	Hold	10,000	–	–	﹤0.01%	315
2022 Q3	$35K	Hold	10,000	–	–	﹤0.01%	331
2022 Q2	$30K	Hold	10,000	–	–	﹤0.01%	328
2022 Q1	$88K	Hold	10,000	–	–	0.01%	381
2021 Q4	$161K	Hold	10,000	–	–	0.01%	340
2021 Q3	$209K	Hold	10,000	–	–	0.01%	329
2021 Q2	$269K	Hold	10,000	–	–	0.02%	299
2021 Q1	$319K	Hold	10,000	–	–	0.02%	265
2020 Q4	$229K	Hold	10,000	–	–	0.02%	293
2020 Q3	$252K	Hold	10,000	–	–	0.02%	252
2020 Q2	$279K	Hold	10,000	–	–	0.03%	225
2020 Q1	$58K	Hold	10,000	–	–	0.01%	262
2019 Q4	$109K	Hold	10,000	–	–	0.01%	300
2019 Q3	$128K	Hold	10,000	–	–	0.01%	313
2019 Q2	$170K	Hold	10,000	–	–	0.02%	317
2019 Q1	$180K	Hold	10,000	–	–	0.02%	306
2018 Q4	$127K	Buy	+10,000	New	+$168K	0.02%	151

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northeast Financial Consultants's MGNX Position: Q2 2025 in Review

Northeast Financial Consultants opened a new position in MacroGenics (MGNX) in Q2 2025: 10,000 shares worth $12.1K. The stake represents ﹤0.01% of the portfolio and ranks #299 among its holdings. This is a return to the name: Northeast Financial Consultants previously reported a position in MGNX as recently as Q3 2024.

Northeast Financial Consultants first reported a position in MGNX in Q4 2018 and has held it in 25 quarters since. The position peaked at $319K in Q1 2021. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

Northeast Financial Consultants held 10,000 shares of MacroGenics worth $12.1K as of Q2 2025.
MacroGenics was a new Northeast Financial Consultants position in Q2 2025.
MacroGenics made up ﹤0.01% of Northeast Financial Consultants's portfolio in Q2 2025, its #299 holding.
Northeast Financial Consultants first reported a position in MacroGenics in Q4 2018 and has held it in 25 quarters since.
Northeast Financial Consultants's MacroGenics position peaked at $319K in Q1 2021.
112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on Northeast Financial Consultants's 13F filing for Q2 2025, filed 15 Aug 2025.